Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Hart

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Digestive Diseases and Sciences|November 1, 1987
Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Analog of human growth hormoneM H Hart, C K Phares, S H Erdman, et al.
Pediatrics|January 1, 1992
Influence of portagen and pregestimil on essential fatty acid status in infantile liver diseaseS S Kaufman, D J Scrivner, N D Murray, et al.
Gastroenterology|June 1, 1989
Suppression of diamine oxidase activity enhances postresection ileal proliferation in the ratS H Erdman, J H Park, J S Thompson, et al.
American Journal of Diseases of Children (1960)|March 1, 1991
Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twinsM H Hart, S S Kaufman, J A Vanderhoof, et al.
Annals of the Rheumatic Diseases|October 25, 2014
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding regionK A van Schie, M H Hart, E R de Groot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
The release of interleukin-8 during intravenous bolus treatment with interleukin-2J W Baars, G J Wolbink, M H Hart, et al.
Annals of the Rheumatic Diseases|April 10, 2015
Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et alK A van Schie, M H Hart, E R de Groot, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patientsA Jamnitski, C L Krieckaert, M T Nurmohamed, et al.
European Journal of Biochemistry|March 15, 1996
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicingG Müller-Newen, C Köhne, R Keul, et al.
European Journal of Biochemistry|December 1, 1995
Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterizationO Weiergräber, U Hemmann, A Küster, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Digestive Diseases and Sciences|November 1, 1987
Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Analog of human growth hormoneM H Hart, C K Phares, S H Erdman, et al.
Pediatrics|January 1, 1992
Influence of portagen and pregestimil on essential fatty acid status in infantile liver diseaseS S Kaufman, D J Scrivner, N D Murray, et al.
Gastroenterology|June 1, 1989
Suppression of diamine oxidase activity enhances postresection ileal proliferation in the ratS H Erdman, J H Park, J S Thompson, et al.
American Journal of Diseases of Children (1960)|March 1, 1991
Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twinsM H Hart, S S Kaufman, J A Vanderhoof, et al.
Annals of the Rheumatic Diseases|October 25, 2014
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding regionK A van Schie, M H Hart, E R de Groot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
The release of interleukin-8 during intravenous bolus treatment with interleukin-2J W Baars, G J Wolbink, M H Hart, et al.
Annals of the Rheumatic Diseases|April 10, 2015
Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et alK A van Schie, M H Hart, E R de Groot, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patientsA Jamnitski, C L Krieckaert, M T Nurmohamed, et al.
European Journal of Biochemistry|March 15, 1996
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicingG Müller-Newen, C Köhne, R Keul, et al.
European Journal of Biochemistry|December 1, 1995
Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterizationO Weiergräber, U Hemmann, A Küster, et al.
Pageof 3